Lobe Sciences Ltd Sustainability Reports
Lobe Sciences Ltd. is a biopharmaceutical company specializing in the research and development of drug therapies and medical foods to treat rare and orphan diseases, including chronic cluster headaches and sickle cell disease.
Sector: Manufacturing
Country: Canada
Exchange: Canadian Securities Exchange
FIGI: BBG00PD5TCH2
1 reports from 2024 to 2024
Company Profile
Lobe Sciences Ltd. is a biopharmaceutical company specializing in the research and development of drug therapies and medical foods to treat rare and orphan diseases, including chronic cluster headaches and sickle cell disease.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
